ISIS Financial Facts
Net loss: 7.35MInvestment income: 989K
See Full Income Statement
Accrued compensation: 11.01M
Other current assets: 15.24M
See Full Balance Sheet
Isis Pharmaceuticals, Inc. (ISIS) Earnings
|
Expand Research on ISIS
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +296.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +4.5% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/9/15 | Q315 | -$0.30 | -$0.31 | +$0.01 | $49.1M | $52.93M | N/A | Details | |||
8/4/15 | Q215 | $0.29 | $0.29 | $0.00 | $120.4M | $114.93M | N/A | Details | |||
5/5/15 | Q115 | -$0.14 | -$0.21 | +$0.07 | $62.6M | $52.74M | N/A | Details | |||
2/27/15 | Q414 | $0.25 | $0.02 | +$0.23 | $84.9M | $74.58M | N/A | Details | |||
11/7/14 | Q314 | -$0.23 | -$0.20 | -$0.03 | $44.1M | $45.8M | N/A | Details | |||
8/4/14 | Q214 | -$0.10 | -$0.12 | +$0.02 | $57.1M | $45.6M | N/A | Details | |||
5/6/14 | Q114 | -$0.27 | -$0.23 | -$0.04 | $28.2M | $35.12M | N/A | Details | |||
2/28/14 | Q413 | -$0.21 | -$0.17 | -$0.04 | $42.2M | $34.2M | N/A | Details |